{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1116.510",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2018-07-24T01:07:49.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.510",
  "version": "20180724",
  "name": "Patient Reasons for Not Performing Flow Cytometry",
  "status": "active",
  "date": "2018-07-24T01:00:01-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "concept": [
          {
            "code": "2P",
            "display": "Performance Measure Exclusion Modifier due to Patient Reasons"
          },
          {
            "code": "3170F",
            "display": "Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"
          }
        ]
      }
    ]
  }
}